{"abstract":"The National Institute on Aging and the National Cancer Institute, institutes of the National Institutes of Health, Department of Health and Human Services, are contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the U.S. and foreign Patents and Patent Applications listed in the Supplementary Information section of this notice to AevisBio, Inc. located in 814 W Diamond Ave., Suite 203, Gaithersburg, MD 20870.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2020/04/23/2020-08560.html","cfr_references":[],"citation":"85 FR 22743","comment_url":null,"comments_close_on":"2020-05-08","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license which are received by the National Institute on Aging c/o National Cancer Institute's Technology Transfer Center on or before May 8, 2020 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2020-08560","effective_on":null,"end_page":22743,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2020/04/23/2020-08560.xml","html_url":"https://www.federalregister.gov/documents/2020/04/23/2020-08560/prospective-grant-of-an-exclusive-patent-license-thio-compounds-and-thalidomide-analogues-for-the","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2020-08560?publication_date=2020-04-23","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2020-04-23/2020-08560/mods.xml","not_received_for_publication":null,"page_length":1,"page_views":{"count":233,"last_updated":"2026-07-27 10:15:03 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2020-04-23/pdf/2020-08560.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2020-08560.pdf?1587559536","publication_date":"2020-04-23","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2020/04/23/2020-08560.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2023-02-28T18:37:51Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":22743,"subtype":null,"title":"Prospective Grant of an Exclusive Patent License: Thio Compounds and Thalidomide Analogues for the Treatment of Neurological Diseases","toc_doc":null,"toc_subject":null,"topics":[],"type":"Notice","volume":85}